Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 02/12 04:14:59 pm
4.72 USD   +5.36%
02/10 ARIAD PHARMACEU : to Present at the RBC Capital Markets Healthcare C..
02/02 ARIAD PHARMACEU : to Webcast Conference Call on Fourth Quarter and Y..
02/01 ARIAD PHARMACEU : Announces FDA Clearance to Begin Clinical Developm..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
4.6(c) 4.61(c) 4.61(c) 4.48(c) 4.72(c) Last
4 058 438 2 672 159 2 377 721 3 601 259 2 770 355 Volume
-9.27% +0.22% 0.00% -2.82% +5.36% Change
More quotes
Financials ($)
Sales 2015 126 M
EBIT 2015 -221 M
Net income 2015 -236 M
Debt 2015 10,8 M
Yield 2015 -
Sales 2016 218 M
EBIT 2016 -181 M
Net income 2016 -187 M
Finance 2016 28,9 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 7,16x
EV / Sales 2016 3,96x
Capitalization 893 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
02/10 ARIAD PHARMACEUTICALS : to Present at the RBC Capital Markets Healthcare Confere..
02/02 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Fourth Quarter and Year-En..
02/01 ARIAD PHARMACEUTICALS : Announces FDA Clearance to Begin Clinical Development of..
01/27 ARIAD PHARMACEUTICALS : Reports Inducement Grant to New Chief Executive Officer
01/21 ARIAD and Otsuka Submit New Drug Application in Japan for Ponatinib
01/21 ARIAD PHARMACEUTICALS : Announces Termination of Shareholder Rights Plan
01/15 ARIAD PHARMACEUTICALS : Reports Inducement Grant to New Chief Executive Officer
01/13 ARIAD PHARMACEUTICALS : Entry into a Material Definitive Agreement, Termination ..
More news
Sector news : Bio Therapeutic Drugs
02/13 LONZA : Pease Lonza may add up to 400 jobs Firm requests city cut building permi..
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12 AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
01/08 Regulatory application submitted in Japan for Iclusig for the treatment of ce..
2015 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
2015 New chief at ARIAD Pharma
2015 PREMARKET BIOTECH DIGEST : Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Gui..
2015 ARIAD Pharma lowers 2015 revenue guidance as negotiations in France over Iclu..


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions